Giedre Krenciute
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Giedre Krenciute as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:39 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05835687 · Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS TumorsSt. Jude Children's Research Hospital · active not recruiting · Central Nervous System Neoplasms, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- GENETICALLY ENGINEERED T CELLS FOR DIPGR01NS122859 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2022 to 2026 · $503,626 awarded in 2026Same name and institution; not confirmed by an ID
- Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline gliomaU01CA281823 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2023 to 2026 · $786,304 awarded in 2026Same name and institution; not confirmed by an ID
- Improving genetically engineered T cells for medulloblastomasR01NS121249 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2021 to 2025 · $444,775 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).